Login
$ASMB
$20.30 +$0.00 (0.0%) After hours

$ASMB 3 SEC Filings

Filed On Filing
15 Mar 2024 Form 3: Cook Robert Donald Ii, Director

No securities owned

11 Dec 2023 Form 3: Cihlar Tomas, Director

No securities owned

13 Nov 2023 Form 3: Gaggar Anuj, Chief Medical Officer

No securities owned

31 Oct 2023 Form 3: Schornstein Alexander, 10% owner

Holds 6,060,000 shares of Common Stock

25 Oct 2023 Form 3: Gilead SCIENCES, Inc., 10% owner

Holds 13,073,668 shares of Common Stock

18 Sep 2023 Form 3: White Nicole S, Chief Manufacturing Officer

Holds 86,142 shares of Common Stock

13 Sep 2022 Form 3: Bjorkquist Jeanette M, Principal Accounting Officer

Holds 15,830 shares of Common Stock

20 Jul 2021 Form 3: Houghton Michael, Director

No securities owned

04 Jun 2021 Form 3: Samar Michael P., SVP, Fin. & Bus. Ops, PFO, PAO

Holds 40,845 shares of Common Stock

24 May 2021 Form 3: Johnson-Pratt Lisa, Director

No securities owned

21 Oct 2020 Form 3: Consylman Gina, Director

No securities owned

29 May 2020 Form 3: Delaney William E Iv, CSO, Virology

No securities owned

30 Mar 2020 Form 3: Okazaki Jason A, Chief Legal & Business Officer

Holds 2,500 shares of Common Stock

07 Nov 2019 Form 3: Stamm Luisa M, Chief Medical Officer

No securities owned

28 Oct 2019 Form 3: Russo Thomas Joseph, CFO

No securities owned

08 Aug 2019 Form 3: McHutchison John G, Director

No securities owned

09 May 2019 Form 3: Samar Michael P., See Remarks

Holds 17,000 shares of Common Stock

02 Apr 2018 Form 3: Papkoff Jacqueline Sybil, See remarks

No securities owned

12 Mar 2018 Form 3: Kim Helen Susan, Director

No securities owned

12 Mar 2018 Form 3: Cooper Graham K, See Remarks

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support